Matthew Zimmerman
Hackensack Meridian Health(US)Center for Discovery(US)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Cancer therapeutics and mechanisms, Antibiotic Resistance in Bacteria, Biochemical and Molecular Research
Most-Cited Works
- → The association between sterilizing activity and drug distribution into tuberculosis lesions(2015)465 cited
- → Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.(1989)328 cited
- → CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis(2022)218 cited
- → Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo(2016)215 cited
- → Tuberculosis drugs’ distribution and emergence of resistance in patient’s lung lesions: A mechanistic model and tool for regimen and dose optimization(2019)199 cited
- → Bedaquiline and Pyrazinamide Treatment Responses Are Affected by Pulmonary Lesion Heterogeneity in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice(2016)152 cited
- → Plasticity of the Mycobacterium tuberculosis respiratory chain and its impact on tuberculosis drug development(2019)139 cited
- → Interferon alfa-2b for chronic hepatitis C: effects of dose increment and duration of treatment on response rates(1995)118 cited
- → Statin adjunctive therapy shortens the duration of TB treatment in mice(2016)109 cited
- → Adjunctive Host-Directed Therapy With Statins Improves Tuberculosis-Related Outcomes in Mice(2019)90 cited